|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1500 AUD | -3.23% |
|
0.00% | - |
| 06:38pm | Amplia Therapeutics Limited Announces Appointment of Brett Carter to Board, Effective July 6, 2026 | CI |
| 07-06 | Amplia Therapeutics Limited Announces Board Changes, Effective June 30, 2026 | CI |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 77 | - |
| Change | - | - | 343.99% | -36.14% | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 61.5 | 55.5 |
| Change | - | - | 241.42% | -33.67% | -9.76% |
| P/E | -2.64x | -3.27x | -14.3x | -6.52x | -25x |
| PBR | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.2x | 0.3x |
| Capitalization / Revenue | - | - | - | - | 7.7x |
| EV / Revenue | - | - | - | - | 5.55x |
| EV / EBITDA | - | - | -11.2x | -5.35x | -15.9x |
| EV / EBIT | - | - | -11.1x | -5.3x | -15.4x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.006 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 10 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -3.5 |
| EBIT 1 | - | - | -8.389 | -11.6 | -3.6 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -3.6 |
| Net Debt 1 | - | - | -27.85 | -15.5 | -21.5 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1500 | 0.1500 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - |
| Announcement Date | 30/05/23 | 30/05/25 | 29/05/26 | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.74x | - | -5.57x | - | 55.21M | |
| 35.05x | 8.83x | 27.39x | 0.05% | 57.73B | |
| 20.57x | 6.33x | 13.71x | 1.47% | 54.69B | |
| -18.68x | 4.59x | -8.02x | -.--% | 23.75B | |
| -42.24x | 13.99x | -40.8x | -.--% | 24.18B | |
| 24.71x | 4.89x | 12.71x | -.--% | 19.82B | |
| 23.97x | 4.73x | 15.69x | -.--% | 17.14B | |
| 50.04x | 20.37x | 54.66x | 0.06% | 16.75B | |
| -546.55x | 37.62x | -4194.16x | -.--% | 15.57B | |
| 17.46x | 5.07x | 11.84x | -.--% | 13.96B | |
| Average | -44.24x | 11.82x | -411.25x | 0.18% | 24.36B | |
| Weighted average by Cap. | -19.87x | 10.18x | -256.65x | 0.35% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
